<?xml version="1.0" encoding="utf-8"?><rss version="2.0">
<channel>
<title>Health News : Articles : Rss : Job Opportunities much more...</title> 
<link>http://www.ehealthguide.info/</link> 
<description>Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient&#039;s, Health Care staff, Explains Patient Family Education and Rights.
Best Articles, Notes, Organizations and there activities to explore, to facilitate your patients, and providing quality and safety in the health care organizations. </description> 
<lastBuildDate>Mon Dec 2008</lastBuildDate>
<generator>eHealth Guide RSS - http://www.ehealthguide.info</generator>
<item>
<title>Interferon Beta&amp;amp;#45;1a Offers A Near 3&amp;amp;#45;fold Improvement In Injection Tolerability Compared With The Original Formulation &amp;amp;#45; 2&amp;amp;#45;Year Phase IIIb Data</title> 
<link>http://www.ehealthguide.info/read_new71944.html</link> 
<description>Merck Serono, a division of Merck KGaA, announced today new results of a two year (96 week) Phase IIIb study in 260 patients which has shown that the new formulation of Rebif&amp;#174; (interferon beta&amp;#45;1a) offers a near three&amp;#45;fold improvement in injection tolerability for patients with relapsing remitting multiple sclerosis (RRMS). These results are compared with historical data for the previous formulation of Rebif&amp;#174; (30.8% versus 85.8%)...</description>
<pubDate>Sun Oct 2007</pubDate>
</item>
    	
	
	
	
</channel>
</rss>